ALYSA HARNER: Open Payments
NPI 1851122642 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$228 in 14 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $15 · 2025 $228
Food & beverage: $228
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Novo Nordisk Inc | 3 | $46 |
| Lilly USA, LLC | 2 | $30 |
| Amgen Inc. | 1 | $16 |
| PFIZER INC. | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: GEMTESA, MOUNJARO, Wegovy, Ozempic, KRYSTEXXA, NURTEC ODT, M-M-R II.
Industry payments across NE — which companies pay providers there.
